Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,872

Class I recallsReasonable probability of serious health consequences

24,509

Class II recallsTemporary or medically reversible health consequences

2,932

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,096 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/fsis-issues-public-health-alert-meat-and-poultry-products-due-misbranding-andPublished November 6, 2026

Most affected stateHawaii 200 recalls mention this state

Advertisement

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 8, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix AT-6 Papa 30 mg/Phent 4 mg/Atrop. 0.3 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1343-05

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix Alprostadil/ Phentolamine/Papavarin 40 mcg/1 mg/30 mg 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1330-05

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix 30-1-30 Papavarin 30 mg/Phentolamine 1 mg/Alprostadil 30 mg/mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1319-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix T 101 Alprostadil/Papverine/Phentolamine 5.9 mcg/17.65 mg/0.59 mcg per mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1336-05

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix QM10 Papaverine 30 mg/Phentolamine 4 mg/Atropine 1 mg/PGE 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1352-05

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix BM3 Papaverine 30 mg/Phentolamine 1 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1354-03

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Trimix BM3 Papaverine 60 mg/Phentolamine 4 mg Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1310-03

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Tri-Mix Papaverine/Phentolamine/Alprostadil 150 mg/5 mg/50 mcg a) Injectable NDC 69699-1332-05 b) (LYO) Powder NDC 69699-1332-05, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Tri-Mix XL 150 mg/10 mg/100 mcg a) Injectable NDC 69699-1353-10; b) (LYO) Powder NDC 69699-1353-10, Pharm D Solutions, Houston, Texas

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Tilarginine Acetate 50 mg/mL, 10 mL, Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1461-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sterile Water 50 mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1421-50

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

0.9% Sodium Chloride for Injection, 50 mL bags, Pharm D Solutions, Houston, Texas --- NDC 69699-1426-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Slenderella Compound Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-30

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/GHRP-2/Theanine/Mannitol 15 mg/6 mg/75 mg/300 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1731-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/GHRP-2/GHRP-6 Mannitol 9 mg/9 mg/9 mg/300 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1726-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/GHRP-2 9 mg/9 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1715-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/GHRP-2 9 mg-6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1728-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/GHRP-2 18 mg/6 mg powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1748-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/GHRP-2 6 mg/6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1727-10

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: February 5, 2021Historical recordClass II

Sermorelin/Ipamorelin 18 mg/15 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1759-18

by Pharm D Solutions, LLC

Reason: Lack of Assurance of Sterility
Published: November 7, 2018
Distribution: Nationwide

View recall →

Data last updated: November 8, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.